» Articles » PMID: 7535237

Functional Role of Cell Surface Integrins on Human Trophoblast Cell Migration: Regulation by TGF-beta, IGF-II, and IGFBP-1

Overview
Journal Exp Cell Res
Specialty Cell Biology
Date 1995 Apr 1
PMID 7535237
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Trophoblast invasion of the human uterus is stringently controlled by the microenvironment. Invasive extravillous trophoblast cells in situ as well as in culture express a selective repertoire of cell surface integrins. Since migration is a necessary step in the invasion cascade, we tested whether certain integrins or invasion-regulating molecules, i.e., TGF-beta, IGF-II, and IGFBP-1 produced at the fetomaternal interface had a functional role on trophoblast migration. Flow cytometric analysis of integrin expression and the use of an in vitro cell migration assay revealed that exogenous TGF-beta upregulates integrin expression and reduces migratory ability to the invasive trophoblast, whereas IGF-II has no effect on integrin expression but stimulates migration. Trophoblast migration was inhibited in the presence of alpha 5 and beta 1 integrin blocking antibodies, indicating its dependence on the expression of these subunits. Furthermore, IGFBP-1, which contains an RGD sequence recognizing certain integrins, stimulated migration, an effect that was blocked by pretreatment with anti-alpha 5 or -beta 1 blocking Abs. These studies demonstrate that the migration of first trimester invasive trophoblast in vitro (1) requires the expression of alpha 5 and beta 1 integrin subunits, (2) is inhibited by TGF-beta, possibly due to increased cell adhesiveness to the extracellular matrix, (3) is stimulated by IGF-II by an as yet undetermined mechanism, and (4) is stimulated by IGFBP-1, likely by interaction with the RGD binding site of the alpha 5 beta 1 integrin. The invasion-regulating effects of TGF-beta, IGF-II, and IGFBP-1 may thus, at least in part, be due to their migration-regulating effects on the invasive trophoblast.

Citing Articles

TGFβ signalling: a nexus between inflammation, placental health and preeclampsia throughout pregnancy.

Horvat Mercnik M, Schliefsteiner C, Sanchez-Duffhues G, Wadsack C Hum Reprod Update. 2024; 30(4):442-471.

PMID: 38519450 PMC: 11215164. DOI: 10.1093/humupd/dmae007.


Modulation of fetoplacental growth, development and reproductive function by endocrine disrupters.

Basak S, Varma S, Duttaroy A Front Endocrinol (Lausanne). 2023; 14:1215353.

PMID: 37854189 PMC: 10579913. DOI: 10.3389/fendo.2023.1215353.


Mechanistic insights into the development of severe fetal growth restriction.

Gumina D, Su E Clin Sci (Lond). 2023; 137(8):679-695.

PMID: 37186255 PMC: 10241202. DOI: 10.1042/CS20220284.


A High-Throughput Toxicity Screen of 42 Per- and Polyfluoroalkyl Substances (PFAS) and Functional Assessment of Migration and Gene Expression in Human Placental Trophoblast Cells.

Blake B, Rickard B, Fenton S Front Toxicol. 2022; 4:881347.

PMID: 35548680 PMC: 9081605. DOI: 10.3389/ftox.2022.881347.


Placental sFlt-1 Gene Delivery in Early Primate Pregnancy Suppresses Uterine Spiral Artery Remodeling.

Aberdeen G, Babischkin J, Lindner J, Pepe G, Albrecht E Endocrinology. 2022; 163(4).

PMID: 35134145 PMC: 8896163. DOI: 10.1210/endocr/bqac012.